A rapid multiparameter approach to study factors that regulate osteoclastogenesis:: Demonstration of the combinatorial dominant effects of TNF-α and TGF-β in RANKL-mediated osteoclastogenesis

被引:18
作者
Huang, W
Drissi, MH
O'Keefe, RJ
Schwarz, EM
机构
[1] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA
关键词
multiparameter; osteoclast; cytokine;
D O I
10.1007/s00223-003-0059-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophages differentiate into osteoclasts in response to the critical cytokine RANKL. However, the efficiency of RANKL-mediated osteoclastogenesis can be profoundly influenced by various cytokines. While studies describing the isolated effects of particular cytokines on osteoclastogenesis have been performed, combinatorial effects of cytokines have not been addressed routinely due to the absence of an efficient assay system. To study the effects of cytokine combinations on osteoclast formation, we performed in vitro assays using either the RAW293 cell line or primary murine splenic macrophages as osteoclast precursors. Using a multiparameter cytokine plating method, we analyzed osteoclastogenesis in response to multiple combinations of the following inflammation-related cytokines: RANKL, IFN-gamma, TNF-alpha, IL-1beta, IL-6, IL-10. We further investigated the role of T-cell-related cytokine combinations on osteoclastogenesis by measuring osteoclast area in response to RANKL with IFN-gamma, IL-2, IL-4, IL-6, TGF-beta, and TNF-alpha. Treatments with RANKL, TNF-alpha, and TGF-beta induced maximal osteoclast formation, suggesting a role for these cytokines in the most aggressive forms of inflammatory bone loss. TNF-alpha alone, however, was unable to induce osteoclast formation in the absence of RANKL despite co-administration of other proinflammatory cytokines. IFN-gamma was a potent inhibitor under all conditions, implicating T cells and NK cells in osteoclast inhibition. These studies demonstrate a rapid screening approach for identifying the potential collective effects of multiple factors on osteoclastic bone resorption.
引用
收藏
页码:584 / 593
页数:10
相关论文
共 24 条
[1]   Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage [J].
Abramson, SB ;
Amin, A .
RHEUMATOLOGY, 2002, 41 (09) :972-980
[2]   Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor [J].
AbuAmer, Y ;
Ross, FP ;
Edwards, J ;
Teitelbaum, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1557-1565
[3]  
Amizuka N, 2000, HISTOL HISTOPATHOL, V15, P957, DOI 10.14670/HH-15.957
[4]   MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES [J].
DALTON, DK ;
PITTSMEEK, S ;
KESHAV, S ;
FIGARI, IS ;
BRADLEY, A ;
STEWART, TA .
SCIENCE, 1993, 259 (5102) :1739-1742
[5]   TGF-β enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF [J].
Galvin, RJS ;
Gatlin, CL ;
Horn, JW ;
Fuson, TR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :233-239
[6]   Regulation of osteoclast activity [J].
Greenfield, EM ;
Bi, YM ;
Miyauchi, A .
LIFE SCIENCES, 1999, 65 (11) :1087-1102
[7]   Regulation of cytokine signaling and inflammation [J].
Hanada, T ;
Yoshimura, A .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) :413-421
[8]   The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption [J].
Hofbauer, LC ;
Khosla, S ;
Dunstan, CR ;
Lacey, DL ;
Boyle, WJ ;
Riggs, BL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) :2-12
[9]   The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine-phosphorylated proteins [J].
Hong, MH ;
Williams, H ;
Jin, CH ;
Pike, JW .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (05) :911-918
[10]   Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor [J].
Horwood, NJ ;
Udagawa, N ;
Elliott, J ;
Grail, D ;
Okamura, H ;
Kurimoto, M ;
Dunn, AR ;
Martin, TJ ;
Gillespie, MT .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (03) :595-603